Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cytek Biosciences (CTKB) Shares Outstanding (2020 - 2025)

Historic Shares Outstanding for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $127.9 million.

  • Cytek Biosciences' Shares Outstanding fell 146.51% to $127.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $127.9 million, marking a year-over-year decrease of 146.51%. This contributed to the annual value of $129.2 million for FY2024, which is 115.44% down from last year.
  • Latest data reveals that Cytek Biosciences reported Shares Outstanding of $127.9 million as of Q3 2025, which was down 146.51% from $127.2 million recorded in Q2 2025.
  • Over the past 5 years, Cytek Biosciences' Shares Outstanding peaked at $136.3 million during Q2 2023, and registered a low of $31.8 million during Q1 2021.
  • For the 5-year period, Cytek Biosciences' Shares Outstanding averaged around $121.7 million, with its median value being $131.5 million (2024).
  • Per our database at Business Quant, Cytek Biosciences' Shares Outstanding skyrocketed by 36352.15% in 2021 and then plummeted by 426.4% in 2024.
  • Quarter analysis of 5 years shows Cytek Biosciences' Shares Outstanding stood at $133.7 million in 2021, then rose by 1.21% to $135.4 million in 2022, then dropped by 3.44% to $130.7 million in 2023, then dropped by 1.15% to $129.2 million in 2024, then dropped by 1.04% to $127.9 million in 2025.
  • Its last three reported values are $127.9 million in Q3 2025, $127.2 million for Q2 2025, and $127.6 million during Q1 2025.